Literature DB >> 7273593

No stereoselective first-pass hepatic extraction of propranolol.

G P Jackman, A J McLean, G L Jennings, A Bobik.   

Abstract

The plasma level: time profile for l-propranolol and total propranolol concentrations were examined in normotensive subjects after intravenous and oral dl-propranolol. l-Propranolol concentrations in plasma accounted for about 60% of total propranolol. This was attributed to lower volume of distribution for the isomer. Mean plasma clearance of 1-propranolol was similarly affected while apparent plasma half-life for the l-isomer and total propranolol were of the same order. Oral bioavailability of 1- and total propranolol averaged 40.7 +/- 8.5% and 42.4 +/- 12.9%. Food and hydralazine increased oral bioavailability of total and l-propranolol by similar magnitudes. We conclude that difference in the kinetics of l- and total propranolol concentrations in plasma are small and probably of no clinical significance. Presystemic clearance of propranolol in man does not appear to be stereospecific.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7273593     DOI: 10.1038/clpt.1981.162

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Mechanisms and variations in the food effect on propranolol bioavailability.

Authors:  H Liedholm; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Food increases the bioavailability of propafenone.

Authors:  J E Axelson; G L Chan; E B Kirsten; W D Mason; R C Lanman; C R Kerr
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

Review 3.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

4.  Prediction of metabolic drug interactions involving beta-adrenoceptor blocking drugs.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1984       Impact factor: 4.335

5.  Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma.

Authors:  F Albani; R Riva; M Contin; A Baruzzi
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

6.  Kinetics and metabolism of (+)-, (-)- and (+/-)-bufuralol.

Authors:  R J Francis; P B East; J Larman
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Effect of hydralazine on the elimination of antipyrine in the rat.

Authors:  C K Svensson; P W Knowlton; J A Ware
Journal:  Pharm Res       Date:  1987-12       Impact factor: 4.200

8.  Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup.

Authors:  Josée Bouchard; Greene Shepherd; Robert S Hoffman; Sophie Gosselin; Darren M Roberts; Yi Li; Thomas D Nolin; Valéry Lavergne; Marc Ghannoum
Journal:  Crit Care       Date:  2021-06-10       Impact factor: 9.097

9.  PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.